What does this research mean for the field?

Daily administration of lithium delays disease progression and improves survival in patients with amyotrophic lateral sclerosis (ALS), driven by neuroprotective mechanisms including the activation of autophagy and preservation of mitochondria. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

February 4, 2008Proceedings of the National Academy of SciencesOpen Access

Lithium delays progression of amyotrophic lateral sclerosis

View Full Paper

Ask AI

Bookmark

Authors

FFFrancesco FornaiUniversity of Pisa PLPatrizia LongoneFondazione Santa Lucia LCLuisa CafaroIstituto Neurologico Mediterraneo

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fornai et al. (2008) studied this question.

synapsesocial.com/papers/6a2484331be36f09b5d3daa3 https://doi.org/10.1073/pnas.0708022105

View Full Paper

Ask AI

Bookmark

February 4, 2008Proceedings of the National Academy of SciencesOpen Access

Lithium delays progression of amyotrophic lateral sclerosis

View Full Paper

Ask AI

Bookmark

Authors

FFFrancesco FornaiUniversity of Pisa PLPatrizia LongoneFondazione Santa Lucia LCLuisa CafaroIstituto Neurologico Mediterraneo

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fornai et al. (2008) studied this question.

synapsesocial.com/papers/6a2484331be36f09b5d3daa3 https://doi.org/10.1073/pnas.0708022105

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark